Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Hanlin Zhang for being awarded the first Oxford-Elysium Fellowship in cellular health.

This three year fellowship is aimed at supporting the brightest and most promising scientists in their early research careers at the University of Oxford.

The award will support his study into autophagy; the intracellular degradation system which recycles damaged cellular components. Decreased autophagy levels have been associated with age-related diseases such as neurodegeneration and cancer. Hanlin aims to elucidate a novel autophagy signaling pathway and identify novel drug targets within this pathway to increase autophagy levels to achieve healthier ageing.

Commenting on his award, Hanlin said "Human ageing is a very complex process and associated with many severe diseases. Autophagy plays a critical role in regulating cell homeostasis and senescence. I am happy and grateful to be awarded this early-career fellowship. It will help me gain a deeper insight into this novel autophagy and ageing pathway, which might help unveil the ageing mystery.”

Hanlin will be based primarily within the Kennedy Institue under the supervision of Prof. Katja Simon.

Funding Body

elysium-logo.jpg

Similar stories

Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases

A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Wellcome Trust Investigator Award for Professor Arnon

Congratulations to Professor Arnon on her successful Wellcome Trust Investigator Award entitled: “Spatiotemporal basis of adaptive immunity in the spleen.”

New research suggests targeting blood vessels could be key to controlling fibrotic disease

By studying blood vessels at single cell resolution, Professor Jagdeep Nanchahal and colleagues found that in Dupuytren’s disease, a fibrotic disorder of the hand, the vasculature is key to orchestrating the development of human fibrosis.

Defining the role of resident memory B cells in the fight against influenza

Researchers at the Kennedy Institute of Rheumatology have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

The COVID-19 Multi-omic Blood Atlas (COMBAT) has identified blood hallmarks of COVID-19 involving particular immune cell populations and their development, components of innate and adaptive immunity, and connectivity with the inflammatory response.